Cleared Traditional

K091814 - FORA D20 BLOOD GLUCOSE PLUS BLOOD PRESSURE MONITORING SYSTEM (FDA 510(k) Clearance)

Also includes:
TD-3263 BLOOD GLUCOSE PLUS BLOOD PRESSURE MONITORING SYSTE
Nov 2009
Decision
155d
Days
Class 2
Risk

K091814 is an FDA 510(k) clearance for the FORA D20 BLOOD GLUCOSE PLUS BLOOD PRESSURE MONITORING SYSTEM. This device is classified as a Glucose Oxidase, Glucose (Class II - Special Controls, product code CGA).

Submitted by Taidoc Technology Corporation (New Taipei City, TW). The FDA issued a Cleared decision on November 20, 2009, 155 days after receiving the submission on June 18, 2009.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K091814 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2009
Decision Date November 20, 2009
Days to Decision 155 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code CGA — Glucose Oxidase, Glucose
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345